We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Global Clinical Lab Services Market to Reach USD 327 Billion by 2025

By LabMedica International staff writers
Posted on 17 Jul 2017
Print article
The global clinical laboratory services market is expected to reach USD 327 billion by 2025, driven by the improvement and implementation of informatics and automated data management solutions to perform seamless operations. The competition among medical device manufacturers for the development of clinical chemistry analyzers that can provide rapid results is also expected to aid the market growth. However, sample preparation and running it through experimental protocols with enhanced productivity still remains a challenge for labs.

These are the latest findings of Grand View Research, Inc. (San Francisco, CA, USA), a market research and consulting company.

In 2016, clinical chemistry services held the largest market share due to the presence of large number of body fluid-based screening solutions. Moreover, the segment caters to a large number of specialty including liver function tests, renal function tests, along with determination of different physiological substances.

Presently, growing concern over cost control, increasing the pace of R&D for new products, and demand for improvement in quality control parameters are some of the factors exerting pressure on lab personnel. Additionally, there has been continuous progress in a number of compounds screened in clinical settings, thus further demanding development in this field. The market players are making continuous efforts to address these challenges in different ways. For instance, vendors are adopting 384-well plates instead of 96-well plates in order to reduce reagent costs and the amount of time required for performing assays.

The emergence of tests that require smaller sample size and easy collection of the sample from patients is anticipated to boost R&D, thereby leading to potential growth prospects. Based on the current level of tests and application, medical microbiology & cytology is expected to record the fastest growth. The ability to provide better testing services at a comparatively lower rate is anticipated to increase the adoption of services by stand-alone laboratories, thereby fueling the market growth.

North America remains the market leader owing to technological advancements and high awareness of medical standards in the region, followed by Europe. However, the regions of Asia and Latin America are expected to witness rapid growth due to growing awareness, increased government initiatives, and favorable regulatory policies.

Related Links:
Grand View Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.